--- title: "US Weekly Recap: Aerospace and healthcare issuers drive late-March filing activity" type: "News" locale: "en" url: "https://longbridge.com/en/news/280852281.md" description: "The week of March 23rd, 2026, saw significant filing activity in the aerospace and healthcare sectors, despite no traditional IPOs. Three blank check companies, including Inflection Point Acquisition VI, raised a total of $220 million targeting technology-enabled businesses. Other notable filings included Alamar Biosciences and Kailera Therapeutics, each raising $100 million in the healthcare sector. Additionally, several SPACs, such as Collective Acquisition II and Oceanhawk Acquisition, also entered the pipeline with substantial funding plans." datetime: "2026-03-27T22:24:09.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280852281.md) - [en](https://longbridge.com/en/news/280852281.md) - [zh-HK](https://longbridge.com/zh-HK/news/280852281.md) --- # US Weekly Recap: Aerospace and healthcare issuers drive late-March filing activity While there were no traditional IPOs this past week, three blank check companies priced, and several sizable deals joined the pipeline. The week’s three blank check IPOs were led by **Inflection Point Acquisition VI** (IPFXU), which raised $220 million to target technology-enabled businesses. Three SPACs also submitted initial filings. **Collective Acquisition II** (CAIIU) plans to raise $220 million, targeting finance, defense technology, and AI. **Oceanhawk Acquisition** (OHACU) plans to raise $200 million, backed by investment firm OceanHawk. **Research Alliance III** (RACC) plans to raise $50 million, formed by RA Capital. 9 Filings During the Week of March 23rd, 2026 Issuer _Business_ Deal Size Sector Lead Underwriter Alamar Biosciences (ALMR) $100M Health Care JP Morgan _Provides a protein biomarker detection platform for disease detection research._ Collective Acquisition II (CAIIU) $220M SPAC Clear Street _Blank check company targeting finance, defense technology, and AI._ Kailera Therapeutics (KLRA) $100M Health Care JP Morgan _Phase 3 biotech developing injectable and oral GLP-1s for obesity._ Yesway (YSWY) $300M Consumer Staples Morgan Stanley _Convenience store chain with over 400 locations throughout seven states._ AsiaPac AdTechinno Group (APAT) $25M Technology Maxim _Hong Kong-based adtech platform provider._ Arxis (ARXS) $400M Industrials Goldman _Aerospace and defense electronics and components manufacturer._ Research Alliance III (RACC) $50M SPAC Leerink Partners _Blank check company formed by RA Capital targeting drug development and healthtech._ Aevex (AVEX) $200M Industrials Goldman _Provides military unmanned aircraft systems and services._ Oceanhawk Acquisition (OHACU) $200M SPAC Benchmark _Blank check company backed by investment firm OceanHawk._ ### Related Stocks - [IPFXU.US](https://longbridge.com/en/quote/IPFXU.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [CYTOF.US](https://longbridge.com/en/quote/CYTOF.US.md) - [ALGS.US](https://longbridge.com/en/quote/ALGS.US.md) - [IPEX.US](https://longbridge.com/en/quote/IPEX.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [GRTX.US](https://longbridge.com/en/quote/GRTX.US.md) - [KLRS.US](https://longbridge.com/en/quote/KLRS.US.md) - [BACQ.US](https://longbridge.com/en/quote/BACQ.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [KPTI.US](https://longbridge.com/en/quote/KPTI.US.md) - [BACQU.US](https://longbridge.com/en/quote/BACQU.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [MBX.US](https://longbridge.com/en/quote/MBX.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) ## Related News & Research - [LifeSci Capital Remains a Buy on MBX Biosciences, Inc. (MBX)](https://longbridge.com/en/news/286648301.md) - [RBC Capital Remains a Buy on Karyopharm Therapeutics (KPTI)](https://longbridge.com/en/news/286559865.md) - [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md) - [Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery](https://longbridge.com/en/news/287100303.md) - [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)